Current NDC auxiliary source row compounder:3259

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 71285-0002
Product Ndc: 71285-0002
Product Ndc Digits: 712850002
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Warm Induction 4 to1 High K (40mEq) 500ml
Proprietary Name Suffix: [empty]
Nonproprietary Name: Warm Induction 4 to1 High K (40mEq) 500ml
Dosage Form Name: SOLUTION
Route Name: INTRACORONARY
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Central Admixture Pharmacy Services, Inc.
Establishment Name: Central Admixture Pharmacy Services, Inc.
Establishment Fei: [empty]
Substance Name: POTASSIUM CHLORIDE; ASPARTIC ACID; TROMETHAMINE; GLUTAMIC ACID; DEXTROSE MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; ANHYDROUS DEXTROSE; CITRIC ACID MONOHYDRATE
Active Ingredients Info: 40 meq/500 mL; 4.9 g/500 mL; 4.05 g/500 mL; 5.35 g/500 mL; 12.6 g/500 mL; 29.5875 g/500 mL; 2.4975 g/500 mL; 52.2 g/500 mL; 3.67875 g/500 mL
History Active Ingredients Raw: POTASSIUM CHLORIDE; ASPARTIC ACID; TROMETHAMINE; GLUTAMIC ACID; DEXTROSE MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; ANHYDROUS DEXTROSE; CITRIC ACID MONOHYDRATE
History Active Ingredients Info Raw: 40 meq/500 mL; 4.9 g/500 mL; 4.05 g/500 mL; 5.35 g/500 mL; 12.6 g/500 mL; 29.5875 g/500 mL; 2.4975 g/500 mL; 52.2 g/500 mL; 3.67875 g/500 mL
History Dosage Raw: SOLUTION
Dea Schedule: [empty]
Package Ndc Raw: 71285-0002-1
Package Ndc: 71285-0002-1
Package Ndc Digits: 7128500021
Package Ndc11: 71285000201
Package Description: 500 mL in 1 BAG (71285-0002-1)
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:3259
Source Row Number: 3259
Source Row Hash: db05ada57d5ceaee56cf4c35b9bf7d95ca1aebf29bb15bacb8eeec2b9348ca16
Import Run Id: 20261026T055812Z
Loaded At: 2026-10-26 06:02:33

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRACORONARY",
    "PRODUCTNDC": "71285-0002",
    "DEASCHEDULE": "",
    "LABELERNAME": "Central Admixture Pharmacy Services, Inc.",
    "SUBSTANCENAME": "POTASSIUM CHLORIDE; ASPARTIC ACID; TROMETHAMINE; GLUTAMIC ACID; DEXTROSE MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; ANHYDROUS DEXTROSE; CITRIC ACID MONOHYDRATE",
    "DOSAGEFORMNAME": "SOLUTION",
    "NDCPACKAGECODE": "71285-0002-1",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Warm Induction 4 to1 High K (40mEq) 500ml",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "Warm Induction 4 to1 High K (40mEq) 500ml",
    "PACKAGEDESCRIPTION": "500 mL in 1 BAG (71285-0002-1) ",
    "ACTIVEINGREDIENTSINFO": "40 meq/500 mL; 4.9 g/500 mL; 4.05 g/500 mL; 5.35 g/500 mL; 12.6 g/500 mL; 29.5875 g/500 mL; 2.4975 g/500 mL; 52.2 g/500 mL; 3.67875 g/500 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:3259
Source Row Number: 3259
Status Scope: package
Lookup Ndc: 71285-0002-1
Lookup Ndc Digits: 7128500021
Product Ndc: 71285-0002
Product Ndc Digits: 712850002
Package Ndc: 71285-0002-1
Package Ndc Digits: 7128500021
Package Ndc11: 71285000201
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: db05ada57d5ceaee56cf4c35b9bf7d95ca1aebf29bb15bacb8eeec2b9348ca16
Import Run Id: 20261026T055812Z
Loaded At: 2026-10-26 06:02:33